{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:05:03Z","timestamp":1767830703859,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00404-010-1790-9","type":"journal-article","created":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T10:31:21Z","timestamp":1291717881000},"page":"923-929","source":"Crossref","is-referenced-by-count":17,"title":["Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol\u2013cyproterone acetate"],"prefix":"10.1007","volume":"284","author":[{"given":"Funda","family":"Gode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem","family":"Karagoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemal","family":"Posaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahadir","family":"Saatli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Secil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahri","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"1790_CR1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Y\u0131ld\u0131z BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745\u20132749","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","volume":"114","author":"ACOG Practice Bulletin","year":"2009","unstructured":"ACOG Practice Bulletin (2009) Clinical management guidelines for obstetrician\u2013gynecologists: polycystic ovary syndrome. Obstet Gynecol 114:936\u2013949","journal-title":"Obstet Gynecol"},{"issue":"7","key":"1790_CR3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0029-1242715","volume":"35","author":"W Mak","year":"2009","unstructured":"Mak W, Dokras A (2009) Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis. Semin Thromb Hemost 35(7):613\u2013620","journal-title":"Semin Thromb Hemost"},{"key":"1790_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","volume":"11","author":"J Vrbikova","year":"2005","unstructured":"Vrbikova J, Cibula D (2005) Combined oral contraceptives in the treatment of polycystic ovary syndrome. Hum Reprod Update 11:277\u2013291","journal-title":"Hum Reprod Update"},{"key":"1790_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/humrep\/del407","volume":"22","author":"S Nader","year":"2007","unstructured":"Nader S, Diamanti-Kandarakis E (2007) Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod 22:317\u2013322","journal-title":"Hum Reprod"},{"key":"1790_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-992931","volume":"26","author":"BO Yildiz","year":"2008","unstructured":"Yildiz BO (2008) Oral contaceptives in polycystic ovary syndrome: risk-benefit assesment. Semin Reprod Med 26:111\u2013120","journal-title":"Semin Reprod Med"},{"key":"1790_CR7","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","volume":"90","author":"JP Baillargeon","year":"2005","unstructured":"Baillargeon JP, McClish DK, Essah PA, Nestler JE (2005) Association between the current use of low-dose oral contraceptives and cadiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 90:3863\u20133870","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","volume":"115","author":"MW Lorenz","year":"2007","unstructured":"Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459\u2013467","journal-title":"Circulation"},{"key":"1790_CR9","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1161\/01.CIR.0000147540.88559.00","volume":"110","author":"M Juonala","year":"2004","unstructured":"Juonala M, Viikari J, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari OT (2004) Interrelations between brachial endothelial function and carotid intima-media thickness in young adults. Circulation 110:2918\u20132923","journal-title":"Circulation"},{"key":"1790_CR10","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","volume":"89","author":"N Boulman","year":"2004","unstructured":"Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z (2004) Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 89:2160\u20132165","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2004.04.007","volume":"175","author":"K Lakhani","year":"2004","unstructured":"Lakhani K, Hardiman P, Seifalian AM (2004) Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries. Atherosclerosis 175:353\u2013359","journal-title":"Atherosclerosis"},{"key":"1790_CR12","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","volume":"89","author":"F Orio","year":"2004","unstructured":"Orio F, Palomba S, Cascella T, Simone BD, Biase SD, Russo T, Labella D, Zullo F, Lombardi G, Colao A (2004) Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:4588\u20134593","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR13","doi-asserted-by":"crossref","first-page":"356.e 1","DOI":"10.1016\/j.amjmed.2005.10.059","volume":"119","author":"E Carmina","year":"2006","unstructured":"Carmina E, Orio F, Palombo S, Longo R, Cascella T, Lombardi G, Rini GB, Lobo RA (2006) Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 119:356.e 1\u2013356.e 6","journal-title":"Am J Med"},{"key":"1790_CR14","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.86.6.2453","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453\u20132455","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR15","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-sponsored PCOS Concensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-sponsored PCOS Concensus Workshop Group (2004) Revised 2003 concensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325","journal-title":"Fertil Steril"},{"key":"1790_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalance and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165\u2013169","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","volume":"126","author":"MA Birdsall","year":"1997","unstructured":"Birdsall MA, Farquhar CM, White HD (1997) Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catherization. Ann Intern Med 126:32\u201335","journal-title":"Ann Intern Med"},{"key":"1790_CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","volume":"30","author":"C Meyer","year":"2007","unstructured":"Meyer C, McGrath BP, Teede HJ (2007) Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 30:471\u2013478","journal-title":"Diabetes Care"},{"issue":"4","key":"1790_CR19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.fertnstert.2009.05.044","volume":"94","author":"C Battaglia","year":"2010","unstructured":"Battaglia C, Mancini F, Fabbri R, Persico N, Busacchi P, Facchinetti F, Venturoli S (2010) Polycystic ovary syndrome and cardiovascular risk in young patients treated with drosperinone\u2013ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study. Fertil Steril 94(4):1417\u20131425","journal-title":"Fertil Steril"},{"key":"1790_CR20","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.fertnstert.2008.03.082","volume":"91","author":"ML Luque-Ramirez","year":"2009","unstructured":"Luque-Ramirez ML, Mendieta-Azcona C, Alverez-Blasco F, Escobar-Morreale HF (2009) Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome. Fertil Steril 91:2527\u20132536","journal-title":"Fertil Steril"},{"issue":"2","key":"1790_CR21","doi-asserted-by":"crossref","first-page":"169.e1","DOI":"10.1016\/j.ajog.2009.09.038","volume":"202","author":"F Mancini","year":"2010","unstructured":"Mancini F, Cianciosi A, Persico N, Facchinetti F, Busacchi P, Battaglia C (2010) Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study. Am J Obstet Gynecol 202(2):169.e1\u2013169.e8","journal-title":"Am J Obstet Gynecol"},{"key":"1790_CR22","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1097\/00004872-200312000-00005","volume":"21","author":"NJ Buchner","year":"2003","unstructured":"Buchner NJ, Rump LC (2003) Oral contraceptives and endothelial function: harm or benefit? J Hypertens 21:2227\u20132230","journal-title":"J Hypertens"},{"key":"1790_CR23","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","volume":"89","author":"I Tarkun","year":"2004","unstructured":"Tarkun I, Arslan BC, Canturk Z, Turemen E, Sahin T, Duman C (2004) Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 89:5592\u20135596","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR24","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/00004872-200312000-00015","volume":"21","author":"A Virdis","year":"2003","unstructured":"Virdis A, Pinto S, Versari D, Salvetti G, Bernini G, Fruzetti F, Genazzani AR, Taddei S, Salvetti A (2003) Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens 21:2275\u20132280","journal-title":"J Hypertens"},{"key":"1790_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.contraception.2008.07.024","volume":"79","author":"PM Lizarelli","year":"2009","unstructured":"Lizarelli PM, Martins WP, Vieira CS, Soares GM, Franceschini SA, Ferriani RA, Patta MC (2009) Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Contraception 79:35\u201340","journal-title":"Contraception"},{"key":"1790_CR26","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","volume":"20","author":"B Vural","year":"2005","unstructured":"Vural B, Cal\u0131skan E, Turkoz E, Kilic T, Demirci A (2005) Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 20:2409\u20132413","journal-title":"Hum Reprod"},{"key":"1790_CR27","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.fertnstert.2008.03.023","volume":"91","author":"F Mancini","year":"2009","unstructured":"Mancini F, Cianciosi A, Reggiani GM, Facchinetti F, Battaglia C, Aloysio D (2009) Endothelial function and its relation to leptin, homocysteine, and insulin resistance in normalweight and overweight eumenorrheic women and PCOS patients: a pilot study. Fertil Steril 91:2537\u20132544","journal-title":"Fertil Steril"},{"key":"1790_CR28","first-page":"418","volume":"25","author":"D Karasek","year":"2006","unstructured":"Karasek D, Vaverkova H, Halenka M, Budikova M, Novoty D (2006) Brachial endothelial function in subjects with familial combined hyperlipidemiaand its relationships to carotid artery intima-media thickness. Int Angiol 25:418\u2013426","journal-title":"Int Angiol"},{"key":"1790_CR29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.STR.0000258003.31194.0a","volume":"38","author":"HM Johnson","year":"2007","unstructured":"Johnson HM, Douglas PS, Srinivasan SR, Bond MG, Tang R, Li S, Chen W, Berenson GS, Stein JH (2007) Predictors of carotid intima media thickness progression in young adults: the Bogalusa Heart Study. Stroke 38:900\u2013905","journal-title":"Stroke"},{"key":"1790_CR30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1467-789X.2009.00588.x","volume":"10","author":"E Diamanti-Kandarakis","year":"2009","unstructured":"Diamanti-Kandarakis E, Kandarki E, Christakou C, Panidis D (2009) The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome. Obes Rev 10:431\u2013441","journal-title":"Obes Rev"},{"key":"1790_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1742-1241.2008.01877.x","volume":"63","author":"GM Soares","year":"2009","unstructured":"Soares GM, Vieira CS, Martin W, Dos Reis RM, de Sa MF, Ferriani RA (2009) Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome. Int J Clin Pract 63:160\u2013169","journal-title":"Int J Clin Pract"},{"key":"1790_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/00016348509155113","volume":"64","author":"G Culberg","year":"1985","unstructured":"Culberg G, Hamberger L, Mattsson LA, Mobacken H, Samsioe G (1985) Lipid metabolic studies studies in women with a polycystic ovary syndrome during treatment with a low dose desogestrel\u2013ethinyl estradiol combination. Acta Obstet Gynecol Scand 64:203\u2013207","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1790_CR33","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.80.11.3327","volume":"80","author":"MT Korytkowski","year":"1995","unstructured":"Korytkowski MT, Mokan M, Horwitz MJ, Sl Berga (1995) Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J Clin Endocrinol Metab 80:3327\u20133334","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR34","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","volume":"89","author":"M Guido","year":"2004","unstructured":"Guido M, Romualdi D, Giuliani M, Suriano R, Selvaggi L, Apa R, Lanzone A (2004) Drosperinone for the treatment hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab 89:2817\u20132823","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/09513599009009803","volume":"4","author":"GM Prelevic","year":"1990","unstructured":"Prelevic GM, W\u00fcrzburger MI, Trpkovic D, Balint-Peric L (1990) Effects of a low dose estrogen\u2013anti-androgen combination (Diana-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome. Gynecol Endocrinol 4:157\u2013168","journal-title":"Gynecol Endocrinol"},{"key":"1790_CR36","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0190","volume":"92","author":"M Luque-Ramirez","year":"2007","unstructured":"Luque-Ramirez M, Alvarez-Blasco F, Botella-Carretero JI, Martinez\u2013Bermejo E, Lasuncion MA, Escobar-Morreale HF (2007) Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 92:2453\u20132461","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR37","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","volume":"17","author":"K Elter","year":"2002","unstructured":"Elter K, Imir G, Durmusoglu F (2002) Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study. Hum Reprod 17:1729\u20131737","journal-title":"Hum Reprod"},{"key":"1790_CR38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AOG.0b013e31816a2476","volume":"111","author":"S Cauci","year":"2008","unstructured":"Cauci S, Santolo MD, Culhane JF, Stel G, Gonano F, Guaschino S (2008) Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women. Obstet Gynecol 111:857\u2013864","journal-title":"Obstet Gynecol"},{"key":"1790_CR39","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","volume":"93","author":"K Hoeger","year":"2008","unstructured":"Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS (2008) The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 93:4299\u20134306","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00365510701487727","volume":"68","author":"S Buchbinder","year":"2008","unstructured":"Buchbinder S, Kratzsch J, Fiedler GM, Yar V, Br\u00fcgel M, Leichtle A, Weber W, Alexander H, Matthes G, Thiery J (2008) Body weight and oral contraceptives are the most important modulators of serum CRP levels. Scand J Clin Lab Invest 68:140\u2013144","journal-title":"Scand J Clin Lab Invest"},{"key":"1790_CR41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","volume":"103","author":"G Paradisi","year":"2001","unstructured":"Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD (2001) Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103:1410\u20131415","journal-title":"Circulation"},{"key":"1790_CR42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2265.2008.03506.x","volume":"71","author":"GM Soares","year":"2009","unstructured":"Soares GM, Vieira CS, Martins WP, Fraceschini SA, Reis RM, Silva de Sa MF, Ferriani RA (2009) Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome? Clin Endocrinol 71:406\u2013411","journal-title":"Clin Endocrinol"},{"key":"1790_CR43","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","volume":"22","author":"M Luque-Ramirez","year":"2007","unstructured":"Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF (2007) Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Hum Reprod 22:3197\u20133203","journal-title":"Hum Reprod"},{"key":"1790_CR44","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1210\/jc.2004-1487","volume":"90","author":"C Meyer","year":"2005","unstructured":"Meyer C, McGrath BP, Cameron J, Kostsopoulos D, Teede HJ (2005) Vascular dysfunction and metabolic parameters in polycystic ovary syndrome. J Clin Endocrinol Metab 90:4630\u20134635","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR45","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"CM Deugarte","year":"2005","unstructured":"Deugarte CM, Bartolucci AA, Azziz R (2005) Prevalance of insulin resistance in the polycystic ovary syndrome using the homeostasis model assesment. Fertil Steril 83:1454\u20131460","journal-title":"Fertil Steril"},{"key":"1790_CR46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","volume":"20","author":"D Cibula","year":"2005","unstructured":"Cibula D, Fanta M, Vrbikova J, Stanicka S, Dvorakova K, Hill M, Skhra J, Zivny J, Skrenkova J (2005) The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenemia, SHBG and lipids in PCOS patients. Hum Reprod 20:180\u2013184","journal-title":"Hum Reprod"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1790-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1790-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1790-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:56:15Z","timestamp":1559066175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1790-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1790-9","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}